Longboard Pharmaceuticals, Inc.
LBPHDelisted Dec 2, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001832168
Longboard Pharmaceuticals, Inc. was delisted on Dec 2, 2024; its insiders filed their last Form 4 on Dec 2, 2024; 125 institutions reported holding it in 13F filings for Q3 2024, worth $1.33B in total; Viking Global Investors was the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in Longboard Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 100
- −4 vs. Q1 2024
- Shares held
- 38.8M
- +884.6K (+2.3%) vs. Q1 2024
- Total value
- $1.05B
- +$229.5M (+28.0%) vs. Q1 2024
- New holders
- 20
- 49 more added
- Sold out
- 24
- 27 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LBPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 125 | $1.33B |
| Q2 2024 | 100 | $1.05B |
| Q1 2024 | 105 | $819.5M |
| Q4 2023 | 52 | $99.7M |
| Q3 2023 | 51 | $87.1M |
| Q2 2023 | 50 | $106.7M |
| Q1 2023 | 25 | $51.5M |
| Q4 2022 | 18 | $23.3M |
| Q3 2022 | 19 | $27.0M |
| Q2 2022 | 20 | $23.3M |
| Q1 2022 | 21 | $40.1M |
| Q4 2021 | 21 | $37.8M |
| Q3 2021 | 20 | $68.2M |
| Q2 2021 | 17 | $71.7M |
| Q1 2021 | 22 | $142.8M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Longboard Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AWM Investment Company, Inc. | 0 | $0 | 0.00% | −211,518−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −198,310−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −170,000−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −147,323−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −71,400−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −55,137−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −25,501−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −23,853−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −22,949−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −19,861−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −19,110−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −12,283−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −9,624−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −9,300−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −6,102−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −4,580−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,689−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −1,569−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,358−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −236−100.0% | Sold out |
| LifeSteps Financial, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |